These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2665838

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
    Kristensen IB, Pedersen L, Rø TB, Christensen JH, Lyng MB, Rasmussen LM, Ditzel HJ, Børset M, Abildgaard N.
    Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
    [Abstract] [Full Text] [Related]

  • 23. Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
    Donovan KA, Lacy MQ, Kline MP, Ahmann GJ, Heimbach JK, Kyle RA, Lust JA.
    Leukemia; 1998 Apr; 12(4):593-600. PubMed ID: 9557619
    [Abstract] [Full Text] [Related]

  • 24. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.
    Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM.
    J Immunol; 1987 Mar 01; 138(5):1464-8. PubMed ID: 3492553
    [Abstract] [Full Text] [Related]

  • 25. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A, Moschetta M, Ditonno P, Ria R, Marech I, De Luisi A, Berardi S, Frassanito MA, Angelucci E, Derudas D, Specchia G, Curci P, Pavone V, Rossini B, Ribatti D, Bottazzi B, Mantovani A, Presta M, Dammacco F, Vacca A.
    J Pathol; 2013 Jan 01; 229(1):87-98. PubMed ID: 22847671
    [Abstract] [Full Text] [Related]

  • 26. Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
    Kristensen IB, Christensen JH, Lyng MB, Møller MB, Pedersen L, Rasmussen LM, Ditzel HJ, Abildgaard N.
    Br J Haematol; 2013 May 01; 161(3):373-82. PubMed ID: 23431957
    [Abstract] [Full Text] [Related]

  • 27. CD40 ligation induces lymphotoxin alpha gene expression in human B cells.
    Worm M, Geha RS.
    Int Immunol; 1994 Dec 01; 6(12):1883-90. PubMed ID: 7535097
    [Abstract] [Full Text] [Related]

  • 28. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
    Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R.
    Blood; 1989 Feb 01; 73(2):517-26. PubMed ID: 2783861
    [Abstract] [Full Text] [Related]

  • 29. Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.
    Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M.
    Leuk Lymphoma; 2018 Jan 01; 59(1):178-186. PubMed ID: 28540748
    [Abstract] [Full Text] [Related]

  • 30. Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell lines.
    Bataille R, Klein B, Jourdan M, Rossi JF, Durie BG.
    Cancer; 1989 Mar 01; 63(5):877-80. PubMed ID: 2783661
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A, Korać P, Krišto DR, Ajduković Stojisavljević R, Ivanković D, Dominis M.
    Hum Pathol; 2010 Dec 01; 41(12):1702-10. PubMed ID: 20800871
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone.
    Chenoufi HL, Diamant M, Rieneck K, Lund B, Stein GS, Lian JB.
    J Cell Biochem; 2001 Dec 01; 81(4):666-78. PubMed ID: 11329621
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cytokines involved in the progression of multiple myeloma.
    Merico F, Bergui L, Gregoretti MG, Ghia P, Aimo G, Lindley IJ, Caligaris-Cappio F.
    Clin Exp Immunol; 1993 Apr 01; 92(1):27-31. PubMed ID: 8467562
    [Abstract] [Full Text] [Related]

  • 37. Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.
    Noll JE, Williams SA, Tong CM, Wang H, Quach JM, Purton LE, Pilkington K, To LB, Evdokiou A, Gronthos S, Zannettino AC.
    Haematologica; 2014 Jan 01; 99(1):163-71. PubMed ID: 23935020
    [Abstract] [Full Text] [Related]

  • 38. C-kit ligand (SCF) in human multiple myeloma cells.
    Lemoli RM, Fortuna A.
    Leuk Lymphoma; 1996 Feb 01; 20(5-6):457-64. PubMed ID: 8833403
    [Abstract] [Full Text] [Related]

  • 39. Bone marrow microenvironment and the progression of multiple myeloma.
    Caligaris-Cappio F, Gregoretti MG, Merico F, Gottardi D, Ghia P, Parvis G, Bergui L.
    Leuk Lymphoma; 1992 Sep 01; 8(1-2):15-22. PubMed ID: 1493467
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.